Schonfeld Strategic Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,700	Closed	-$6.71K	–	2482
2023 Q2	$6.71K	Buy	13,700 +300	+2%	+$245	﹤0.01%	1933
2023 Q1	$15.5K	Sell	13,400 -12,100	-47%	-$22.1K	﹤0.01%	1845
2022 Q4	$68.3K	Sell	25,500 -46,300	-64%	-$122K	﹤0.01%	2234
2022 Q3	$206K	Buy	+71,800	New	+$305K	﹤0.01%	2314
2021 Q4	–	Sell	-44,700	Closed	-$874K	–	2670
2021 Q3	$874K	Buy	+44,700	New	+$1.7M	0.01%	1009
2021 Q2	–	Sell	-13,900	Closed	-$699K	–	2429
2021 Q1	$699K	Sell	13,900 -2,550	-16%	-$174K	0.01%	1027
2020 Q4	$1.47M	Buy	+16,450	New	+$1.38M	0.02%	687

Other funds holding CELL

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TAM

Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Schonfeld Strategic Advisors's CELL Position: Q3 2023 in Review

Schonfeld Strategic Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 13,700 shares — an estimated $6.71K sold.

Schonfeld Strategic Advisors first reported a position in CELL in Q4 2020 and held it in 7 quarters. The position peaked at $1.47M in Q4 2020. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

Schonfeld Strategic Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Schonfeld Strategic Advisors sold 13,700 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $6.71K.
Schonfeld Strategic Advisors first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Schonfeld Strategic Advisors's PhenomeX Inc. Common Stock position peaked at $1.47M in Q4 2020.
57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.